Anindita Dutta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anindita Dutta has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Anne Offermann
Institute of Pathology, Universitätsklinikum Schleswig-Holstein, Kiel, Germany
16 shared publications - Antonio Rodriguez-Calero
Department for BioMedical Research, University of Bern, Bern, Switzerland
16 shared publications - Cory Abate-Shen
Columbia University, New York, New York
16 shared publications - Dan Hasson
Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
16 shared publications - Daoud Rahman
Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York
16 shared publications - Elai Davicioni
Veracyte, Inc., South San Francisco, California
16 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Additional analyses related to Figure 3.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Additional analyses related to Figure 3.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Additional analyses related to Figure 4
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Additional analyses related to Figure 4
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Characteristics of GEMM cohort used and raw quantification of ATAD2 expression
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Characteristics of GEMM cohort used and raw quantification of ATAD2 expression
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Oligonucleotides used in this Study
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Oligonucleotides used in this Study
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Additional analyses of MYC regulation of ATAD2.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Additional analyses of MYC regulation of ATAD2.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Additional analysis of ATAD2 expression in prostate cancer.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Additional analysis of ATAD2 expression in prostate cancer.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from ATAD2 Drives Prostate Cancer Progression to Metastasis
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from ATAD2 Drives Prostate Cancer Progression to Metastasis
- Open Access
- 2 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Oligonucleotides used in this Study
- 2 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Oligonucleotides used in this Study
- Open Access
- 2 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Additional analysis of ATAD2 expression in prostate cancer.
- 2 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Additional analysis of ATAD2 expression in prostate cancer.
- Open Access
- 2 May 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Additional analyses related to Figure 3.
- 2 May 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from ATAD2 Drives Prostate Cancer Progression to Metastasis
Additional analyses related to Figure 3.